In particular, CRAF phosphorylation on S338 appears to contribute to CRAF scaffolding function15, 16, 19, leading to enhanced tumour cell proliferation19 and a significant decrease in the survival of breast cancer patients34. Here, RAF1 is linked to neoplasm.